Univercells Technologies

Articles

Scalable rubella production in scale-X™ bioreactor with MRC-5 cells (Nov 2022)

This application note demonstrates the successful transfer, optimization and scale-up of the Rubella vaccine manufacturing process from static flasks to scale-X™ bioreactors.

How to Find Success with Lentiviral Production Using Fixed Bed Bioreactor Technology

Monday, October 17, 2022 at 11am EDT | 4pm BST | 5pm CEST Why would a CDMO to leverage fixed-bed bioreactor technology to develop and produce GMP lentiviral vectors? Join us for a discussion on increasing quality and decreasing time and cost to accelerate time to clinic and market for lentiviral products with technology.

Scalable rubella production in scale-X™ bioreactor with MRC-5 cells

This application note demonstrates the successful transfer, optimization and scale-up of the Rubella vaccine manufacturing process from static flasks to scale-X™ bioreactors.